Search results
Enphase Just Reported Its Lowest Quarterly Revenue in Over 3 Years. Is The Growth Story Officially...
Motley Fool via Yahoo Finance· 1 hour agoThe company was coming out of a multiyear slowdown (and nearly going bankrupt), but growth was...
Here's How Saving Just $5 per Day for 30 Years Can Create a $1 Million Portfolio
Motley Fool via Yahoo Finance· 1 hour agoThrough the benefits of compounding, I'll show you how you can make the most of any savings you may...
14 Best Financial Sector Dividend Stocks To Invest In
Insider Monkey via Yahoo Finance· 7 hours agoIn this article, we discuss 14 best financial sector dividend stocks to invest in. You can skip our...
Why Garmin Stock Was Crushing It This Week
Motley Fool via Yahoo Finance· 1 day agoLongtime GPS technology specialist Garmin (NYSE: GRMN) was charting a clear path to stock price growth over the past few days. It posted first-quarter...
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Zacks via Yahoo Finance· 1 day agoUiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
4 Colossal Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Motley Fool via Yahoo Finance· 12 hours agoThe reason Baidu's stock has struggled recently is because the Chinese economy hasn't bounced back...
UiPath (PATH) Outpaces Stock Market Gains: What You Should Know
Zacks· 6 days agoFree Report) closed the most recent trading day at $19.76, moving +1.54% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of ...
Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in UiPath Inc. (NYSE:PATH)
ETF DAILY NEWS· 6 days agoBank Julius Baer & Co. Ltd Zurich lowered its holdings in UiPath Inc. (NYSE:PATH – Free Report) by...
3 High-Risk, High-Reward Stocks With the Potential to Make You an Overnight Millionaire
InvestorPlace· 3 days agoFor investors, one of the most critical aspects of an investment journey that every investor should...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 11 hours agoMeanwhile, Pfizer's (NYSE: PFE) fortunes have taken a different path. The big pharma stock has...